Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trude Giverhaug

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 11, 2020
Problematic proton pump inhibitorsGuttorm Raknes, Trude Giverhaug
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 17, 2011
[Low dosage naltrexone]Guttorm Raknes, Trude Giverhaug
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|December 11, 2014
[Re: A woman in her forties with cancer, syncope and spasms]Trude Giverhaug, Terje Nilsen
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 11, 2011
[Naltrexone--high expectations to low dosages]Guttorm Raknes, Trude Giverhaug
Pharmacy World & Science : PWS|December 13, 2005
Secondary prevention in coronary heart disease: goal achievement and drug prescribingTrude Giverhaug, Christine Bruland, Thor Trovik
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 20, 2026
Nils Morten Leknes, Anders Vik, Trude Giverhaug
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 2, 2022
Are patients entitled to treatment with drugs that the Decision Forum has rejected?Haakon Lindekleiv, Trude Giverhaug, Marte Lødemel Henriksen
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 26, 2025
Nils Morten Leknes, Anders Vik, Trude Giverhaug
European Journal of Clinical Pharmacology|September 20, 2012
Application of the MAT-CHDSP to assess guideline adherence and therapy goal achievement in secondary prevention of coronary heart disease after percutaneous coronary interventionBeate Hennie Garcia, Lars Småbrekke, Thor Trovik, et al.
Scandinavian Journal of Primary Health Care|September 15, 2021
Home care service employees' contribution to patient safety in clients with dementia who use dietary supplements: a Norwegian surveyHilde Risvoll, Frauke Musial, Marit Waaseth, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 11, 2020
Problematic proton pump inhibitorsGuttorm Raknes, Trude Giverhaug
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 17, 2011
[Low dosage naltrexone]Guttorm Raknes, Trude Giverhaug
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|December 11, 2014
[Re: A woman in her forties with cancer, syncope and spasms]Trude Giverhaug, Terje Nilsen
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 11, 2011
[Naltrexone--high expectations to low dosages]Guttorm Raknes, Trude Giverhaug
Pharmacy World & Science : PWS|December 13, 2005
Secondary prevention in coronary heart disease: goal achievement and drug prescribingTrude Giverhaug, Christine Bruland, Thor Trovik
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 20, 2026
Nils Morten Leknes, Anders Vik, Trude Giverhaug
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 2, 2022
Are patients entitled to treatment with drugs that the Decision Forum has rejected?Haakon Lindekleiv, Trude Giverhaug, Marte Lødemel Henriksen
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 26, 2025
Nils Morten Leknes, Anders Vik, Trude Giverhaug
European Journal of Clinical Pharmacology|September 20, 2012
Application of the MAT-CHDSP to assess guideline adherence and therapy goal achievement in secondary prevention of coronary heart disease after percutaneous coronary interventionBeate Hennie Garcia, Lars Småbrekke, Thor Trovik, et al.
Scandinavian Journal of Primary Health Care|September 15, 2021
Home care service employees' contribution to patient safety in clients with dementia who use dietary supplements: a Norwegian surveyHilde Risvoll, Frauke Musial, Marit Waaseth, et al.
Pageof 2